tetano
Editor, Senior Moderator
Clin Vaccine Immunol. 2015 Nov 11. pii: CVI.00475-15. [Epub ahead of print]
[h=1]Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant.[/h] Chen WH[SUP]1[/SUP], Jackson LA[SUP]2[/SUP], Edwards KM[SUP]3[/SUP], Keitel WA[SUP]4[/SUP], Hill H[SUP]5[/SUP], Noah DL[SUP]6[/SUP], Creech CB[SUP]3[/SUP], Patel SM[SUP]4[/SUP], Mangal B[SUP]5[/SUP], Kotloff KL[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The adjuvant AS03 is stockpiled for future formulation with new and existing vaccines for control of pandemic influenza. We previously reported the immunogenicity of an A/H5N1 vaccine extemporaneously mixed with the AS03 adjuvant for 42 days following vaccination. This report extends those findings to one year after vaccination.
Copyright ? 2015, American Society for Microbiology. All Rights Reserved.
PMID: 26561390 [PubMed - as supplied by publisher]
[h=1]Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant.[/h] Chen WH[SUP]1[/SUP], Jackson LA[SUP]2[/SUP], Edwards KM[SUP]3[/SUP], Keitel WA[SUP]4[/SUP], Hill H[SUP]5[/SUP], Noah DL[SUP]6[/SUP], Creech CB[SUP]3[/SUP], Patel SM[SUP]4[/SUP], Mangal B[SUP]5[/SUP], Kotloff KL[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] The adjuvant AS03 is stockpiled for future formulation with new and existing vaccines for control of pandemic influenza. We previously reported the immunogenicity of an A/H5N1 vaccine extemporaneously mixed with the AS03 adjuvant for 42 days following vaccination. This report extends those findings to one year after vaccination.
Copyright ? 2015, American Society for Microbiology. All Rights Reserved.
PMID: 26561390 [PubMed - as supplied by publisher]